Gregory Adams is listed as an executive officer on 5 SEC Form D filings by 1 issuer between Nov 2020 and Mar 2022: Elucida Oncology, Inc. (Monmouth Junction, NJ — biotechnology — 2020–2022; $35M reported sold to 328 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Eliel Bayever (5 shared filings), Geno Germano (5 shared filings), Kai Ma (5 shared filings), Robert Essner (5 shared filings), Robert Ruffolo (5 shared filings) and 8 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Gregory. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — 1 SEC release, 3 bankruptcy cases matching the name listed in Key records below.
What this means 4 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 5 public filings for Gregory Adams and found 3 differences: Bankruptcy case: Elucida Oncology, Inc. and Pharmaceutics International, Inc; Form D filed 17 days after the first sale; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.